Arachidonic acid metabolites in cardiovascular and metabolic diseases
T Sonnweber, A Pizzini, M Nairz, G Weiss… - International journal of …, 2018 - mdpi.com
Lipid and immune pathways are crucial in the pathophysiology of metabolic and
cardiovascular disease. Arachidonic acid (AA) and its derivatives link nutrient metabolism to …
cardiovascular disease. Arachidonic acid (AA) and its derivatives link nutrient metabolism to …
[HTML][HTML] The role of lipoxygenases in pathophysiology; new insights and future perspectives
R Mashima, T Okuyama - Redox biology, 2015 - Elsevier
Lipoxygenases (LOXs) are dioxygenases that catalyze the formation of corresponding
hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid …
hydroperoxides from polyunsaturated fatty acids such as linoleic acid and arachidonic acid …
Anti-inflammatory therapies for atherosclerosis
M Bäck, GK Hansson - Nature Reviews Cardiology, 2015 - nature.com
The view of atherosclerosis as an inflammatory disease has emerged from observations of
immune activation and inflammatory signalling in human atherosclerotic lesions, from the …
immune activation and inflammatory signalling in human atherosclerotic lesions, from the …
Molecular biology of atherosclerosis
PN Hopkins - Physiological reviews, 2013 - journals.physiology.org
At least 468 individual genes have been manipulated by molecular methods to study their
effects on the initiation, promotion, and progression of atherosclerosis. Most clinicians and …
effects on the initiation, promotion, and progression of atherosclerosis. Most clinicians and …
Oxidative risk for atherothrombotic cardiovascular disease
JA Leopold, J Loscalzo - Free Radical Biology and Medicine, 2009 - Elsevier
In the vasculature, reactive oxidant species, including reactive oxygen, nitrogen, or
halogenating species, and thiyl, tyrosyl, or protein radicals may oxidatively modify lipids and …
halogenating species, and thiyl, tyrosyl, or protein radicals may oxidatively modify lipids and …
What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases
JF Evans, AD Ferguson, RT Mosley… - Trends in …, 2008 - cell.com
Leukotrienes have physiological roles in innate immune responses and pathological roles in
inflammatory diseases, such as asthma, allergic rhinitis and atherosclerosis. Anti-leukotriene …
inflammatory diseases, such as asthma, allergic rhinitis and atherosclerosis. Anti-leukotriene …
The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease
D Poeckel, CD Funk - Cardiovascular research, 2010 - academic.oup.com
Abstract Leukotrienes (LTs) derived from 5-lipoxygenase (5-LO) activity are most widely
known for their actions during acute inflammation and asthma. 5-LO/LT pathway …
known for their actions during acute inflammation and asthma. 5-LO/LT pathway …
Atherosclerotic lesions in mouse and man: is it the same disease?
JF Bentzon, E Falk - Current opinion in lipidology, 2010 - journals.lww.com
Murine atherosclerosis models are highly valuable for identifying atherogenic mechanisms
that can be targeted by preventive medicine. However, models with thrombotic …
that can be targeted by preventive medicine. However, models with thrombotic …
Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers
Common inflammatome gene signatures as well as disease‐specific signatures were
identified by analyzing 12 expression profiling data sets derived from 9 different tissues …
identified by analyzing 12 expression profiling data sets derived from 9 different tissues …
Macrophages: an elusive yet emerging therapeutic target of atherosclerosis
Macrophages are central to the initiation and progression of atherosclerosis and thus can be
very appropriate targets for therapy. Cell adhesion molecules mediating monocytes …
very appropriate targets for therapy. Cell adhesion molecules mediating monocytes …